Shanghai MicroPort MedBot (Group) Co., Ltd. (2252) has published a set of updated terms of reference for its Remuneration and Appraisal Committee. The document emphasizes the Committee’s accountability to the board of directors and outlines how it will formulate and review policies related to remuneration, appraisal, and performance assessments of directors, supervisors, and senior management.

According to the announcement, the Committee will consist of at least three directors, with a majority comprising independent non-executive directors. Its responsibilities cover determining remuneration packages for executive directors and senior management, recommending remuneration for non-executive directors and supervisors, and reviewing performance-based incentives in line with corporate objectives. Furthermore, the document states that any compensation arising from the loss or termination of office must remain fair, consistent with contractual terms, and subject to thorough review.

The updated terms of reference detail a decision-making process that begins with relevant departments providing major financial indicators, operational objectives, and performance data. This information serves as input for the Committee’s annual evaluation, during which directors and senior management present work reports and self-assessments. Based on the findings, proposals for remuneration and incentives are then submitted to the board for review.

The Committee is authorized to seek external professional advice if necessary, with related costs borne by the Company. Additionally, the release highlights confidentiality requirements for all members regarding information discussed at meetings. The new terms become effective upon approval by the board, superseding any previous guidelines governing the Remuneration and Appraisal Committee.